Freeha Rafiq News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Takeda (TSE:4502) (NYSE:TAK) today announced the European Medicines Agency s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of lanadelumab (trade name TAKHZYRO®) …

United kingdomUnited statesDidier relinFreeha rafiqHead of international regulatory at takedaCommittee for medicinal products human useTakeda pharmaceutical companyTakeda pharmaceutical company limitedEuropean medicines agencyEuropean commissionTakeda receives positiveRecommending approvalRoutine preventionRecurrent attacksHereditary angioedemaPatients aged